NRX Pharmaceuticals

+$0.30 (+3.11%) Today
+$0.15 (+1.51%) As of 8:45 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRXP and other ETFs, options, and stocks.

About NRXP

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.

CEO
Jonathan C. Javitt
Employees
2
Headquarters
Wilmington, Delaware
Founded
2017

NRXP Key Statistics

Market Cap
535.05M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
9.09M
High Today
$10.24
Low Today
$9.52
Open Price
$9.65
Volume
1.01M
52 Week High
$76.99
52 Week Low
$6.43

NRXP Earnings

-$0.38
-$0.25
-$0.13
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure